InvestorsHub Logo
Followers 28
Posts 1178
Boards Moderated 0
Alias Born 08/31/2009

Re: cabos_tacos post# 80002

Friday, 04/18/2014 11:49:49 AM

Friday, April 18, 2014 11:49:49 AM

Post# of 97237
OT: cabos...I can see where this would raise questions.

The first point on selling this as a cure...while you are correct it's not a 100% cure rate it is still very high ranging from 92%-100% in the right patient type. See article below...

http://www.hepmag.com/articles/daclatasvir_Sovaldi_2501_25081.shtml

The second point you raise concerning Egypt definitely would raise the question of why the huge gap in treatment cost. If you look at the income for Egyptians it is easy to see that it is drastically less than here in the US. So I believe it is still priced very high for this market due to the avg per person income in Egypt being roughly $5,680 annually. I think it's great they have priced it based on income per capita in the geography they are marketing as it offers PEOPLE the opportunity for a healthier life.

http://weekspopulation.blogspot.com/2011/02/how-poor-is-average-egyptian.html?m=1

I just wanted to expand on why my view is the way it is. I have respect for you opinion and others here on the board and am only expressing how I came to have mine. Thanks for your reply and I am ok on agreeing to disagree! Differing opinions create an expanded point of view, which I am always open to hearing!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.